Insulin-like growth factor I (IGF-I) and cognitive decline in older persons
- PMID: 12714114
- DOI: 10.1016/s0197-4580(02)00136-7
Insulin-like growth factor I (IGF-I) and cognitive decline in older persons
Erratum in
- Neurobiol Aging. 2004 Feb;25(2):271
Abstract
Insulin-like growth factor I (IGF-I) deficiency may be involved in cognitive deficits seen with aging, and in neurodegenerative diseases such as Alzheimer's disease. The objective of this study was to investigate whether IGF-I is associated with cognitive performance and 3-year cognitive decline in 1318 subjects, aged 65-88 years. Cross-sectionally, IGF-I was directly related to information processing speed, memory, fluid intelligence, and Mini-Mental State Examination (MMSE) score, but these associations did not remain significant after adjustment for age and other factors. Analysis in quintiles of IGF-I revealed a threshold effect of low IGF-I on information processing speed, with lower speed in subjects in the lowest quintile of IGF-I (<9.4 nmol/l)(1) versus those in the other four quintiles (fully adjusted B=-0.89; 95% CI, -1.72 to -0.05). This threshold of low IGF-I was also observed for 3-year decline in information processing speed (adjusted RR=1.78; 95% CI, 1.19-2.68). In summary, this study suggests that IGF-I levels below 9.4 nmol/l are negatively associated with both the level and decline of information processing speed.
Similar articles
-
A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly.J Clin Endocrinol Metab. 2000 Dec;85(12):4551-5. doi: 10.1210/jcem.85.12.7033. J Clin Endocrinol Metab. 2000. PMID: 11134107 Clinical Trial.
-
Insulin-like growth factor-1 (IGF-1): relation with cognitive functioning and neuroimaging marker of brain damage in a sample of hypertensive elderly subjects.Arch Gerontol Geriatr. 2009;49 Suppl 1:5-12. doi: 10.1016/j.archger.2009.09.006. Arch Gerontol Geriatr. 2009. PMID: 19836610
-
The role of IGF-I, IGF-II, and IGFBP-3 in male cognitive aging and dementia risk: the Caerphilly Prospective Study.J Alzheimers Dis. 2014;41(3):867-75. doi: 10.3233/JAD-132183. J Alzheimers Dis. 2014. PMID: 24705546
-
Insulin-like Growth Factor 1 (IGF-1) as a marker of cognitive decline in normal ageing: A review.Ageing Res Rev. 2018 Mar;42:14-27. doi: 10.1016/j.arr.2017.12.002. Epub 2017 Dec 9. Ageing Res Rev. 2018. PMID: 29233786
-
Insulin-like growth factor-I, cognition and brain aging.Eur J Pharmacol. 2004 Apr 19;490(1-3):87-95. doi: 10.1016/j.ejphar.2004.02.047. Eur J Pharmacol. 2004. PMID: 15094076 Review.
Cited by
-
(Neuro) Peptides, Physical Activity, and Cognition.J Clin Med. 2020 Aug 10;9(8):2592. doi: 10.3390/jcm9082592. J Clin Med. 2020. PMID: 32785144 Free PMC article. Review.
-
The effects of long-term resistance exercise on the relationship between neurocognitive performance and GH, IGF-1, and homocysteine levels in the elderly.Front Behav Neurosci. 2015 Feb 10;9:23. doi: 10.3389/fnbeh.2015.00023. eCollection 2015. Front Behav Neurosci. 2015. PMID: 25713518 Free PMC article.
-
Brain Health Indicators Following Acute Neuro-Exergaming: Biomarker and Cognition in Mild Cognitive Impairment (MCI) after Pedal-n-Play (iPACES).Brain Sci. 2023 May 23;13(6):844. doi: 10.3390/brainsci13060844. Brain Sci. 2023. PMID: 37371324 Free PMC article.
-
Commonalities in biomarkers and phenotypes between mild cognitive impairment and cerebral palsy: a pilot exploratory study.Aging (Albany NY). 2021 Jan 26;13(2):1773-1816. doi: 10.18632/aging.202563. Epub 2021 Jan 26. Aging (Albany NY). 2021. PMID: 33497355 Free PMC article.
-
Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial.J Alzheimers Dis. 2020;77(4):1793-1803. doi: 10.3233/JAD-200374. J Alzheimers Dis. 2020. PMID: 32925039 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources